Hint mode is switched on Switch off
For swift navigation between sections

Grunenthal
LEI 529900SH895E31PGLA72

Organization name
Grunenthal GmbH
Country name
Germany
Country of registration
Germany
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
993 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Grunenthal is a pharmaceutical company headquartered in Aachen in Germany. The company was founded in 1946 as Chemie Grunenthal and has been continuously family-owned. The company was the first to introduce penicillin into the German market in the postwar period

Awards

Documentation

IFRS/US GAAP reports

2024
2023
2022
2021
2020
2019
2018
Show more Hide
Authorization required
You need to request access

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    529900SH895E31PGLA72
  • NACE
    *** ***
  • NAICS
    *** ***
Registration is required to get access.